Standard BioTools Inc. (LAB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Standard BioTools Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.52x | -4.44x | -2.34x | -0.48x | -5.02x | -8.15x |
| P/B Ratio | 1.15x | 1.31x | -1.18x | -1.12x | 3.14x | 3.11x |
| P/S Ratio | 5.72x | 3.54x | 1.65x | 0.94x | 2.28x | 3.13x |
| Profitability | ||||||
| Gross Margin | 49.9% | 48.3% | 47.4% | 37.8% | 53.1% | 60.3% |
| Operating Margin | -109.3% | -100.5% | -72.0% | -118.6% | -51.7% | -36.9% |
| Net Margin | -87.8% | -79.6% | -70.2% | -194.1% | -45.4% | -38.4% |
| EBITDA Margin | -101.2% | -67.7% | -51.2% | -177.2% | -33.9% | -25.0% |
| Liquidity | ||||||
| Current Ratio | 4.19x | 5.70x | 1.45x | 4.81x | 1.45x | 2.17x |
| Quick Ratio | 4.01x | 5.09x | 1.26x | 4.31x | 1.03x | 1.81x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.07x | -0.66x | -1.26x | 1.18x | 0.69x |
YoY = year-over-year change. Source: FMP..